Page 29 - ISMND_PROGRAM
P. 29

 Glial and vascular contributions to neurodegenerative diseases
2022
PP06
PP07
PP08
Poster Session I, Monday 10 October, 18.00 - 19.30
Annexin A6 in membrane resealing in Alzheimer's disease
1
Katherine Sadleir , Ammaarah Khatri, Regan Andringa-Seed, Alexis Demonbreun,
Elizabeth McNally, Robert Vassar
1Northwestern University, Chicago, USA
Increased plasma and brain Immunoglobulin A in Alzheimer’s disease
is lost in Apolipoprotein E4 carriers
Dovile Poceviciute1, Cristina Nuñez-Diaz1, Bodil Roth2, Shorena Janelidze1,
The Netherlands Brain Bank3, Andreas Giannisis4, Oskar Hansson5, Malin Wennström1 1Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden
2Department of Internal Medicine, Lund University, Skåne University Hospital, Malmö, Sweden 3Netherlands Institute for Neuroscience, Amsterdam, The Netherlands
4Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden 5Memory Clinic, Skåne University Hospital, Malmö, Sweden
The role of alpha 2 adrenergic receptors in oxidative stress, beta amyloid/ tau pathology and neuroinflammation: an in vivo study in a triple transgenic model of Alzheimer’s disease
Lusine Danielyan1,2,3, Daniela Lanvermann1, Margarita Mirumyan2, Magdalina M. Melkonyan4, Marine Buadze1, Libo Yu-Taeger5,6, Elisabeth Singer-Mikosch5,6, Lilit Hunanyan4, Gohar Karapetyan2, Ute Hofmann7, Matthias Schwab1,2,3,7, Konstantin Yenkoyan2, Huu Phuc Nguyen5
1University Hospital of Tuebingen, Department of Clinical Pharmacology, Tuebingen, Germany
2Department of Biochemistry and Laboratory of Neuroscience, Cobrain Center, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia
3Department of Clinical Pharmacology, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia
4Department of Medical Chemistry, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia
5Department of Human Genetics, University of Bochum, Bochum, Germany
6Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany
7Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart , Germany
Interfering with Interferon-Responsive Microglia
1 1 2 3 1,2,3 Amanda McQuade , Nina Drager , Olivia Teter , Kun Leng , Martin Kampmann
1Institute for Neurodegenerative Diseases, University of California San Francisco, San Franscisco, USA 2Department of Bioengineering, University of California San Francisco, San Francisco, USA 3Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, USA
Investigating the effect of lipid dyshomeostasis in Alzheimer’s disease microglia
Aiko Robert1,2, Amanda McQuade3, Martin Giera4, Lena Erlebach5,6, Deborah Kronenberg-Versteeg5,6, Martin Kampmann3,7, Rik van der Kant1,2
1Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), VU University Amsterdam, Amsterdam, Netherlands 2Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, Netherlands 3Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, USA
4Center for Proteomics and Metabolomics, Leiden, Netherlands
5Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
6German Center for Neurodegenerative Diseases, Tübingen, Germany
7Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, USA
PP09
PP10
10 -12 October
Divani Acropolis Athens Greece
PROGRAM & ABSTRACTS • 29


























































   27   28   29   30   31